About NASH Summit
Join Your Peers at the Forefront of Non-alcoholic Steatohepatitis Research
Focussed on Non-Alcoholic Steatohepatitis (NASH), the 2nd NASH Summit will bring together drug developers to solve the challenges they face from drug discovery to late stage clinical development.
Across 3 jam-packed days the brightest minds join the brightest-minds at this summit to discuss the data, insight and lessons learned enabling you to:
- Optimize recapitulation of human NASHin vivo and effectively translate into the clinic
- Validate non-invasive biomarker approaches and technologies to more robustly diagnose and track disease progression
- Improve drug efficacy in both early and late stage NASH by identifying and validating novel targets & drug mechanisms of action
- Define clinical primary and secondary endpoints and road-map your regulatory path to approval
Join your peers in Boston to overcome the challenges that are preventing you from accelerating the development of your NASH candidate.